SEC Form 4 · accession 0001179110-15-013082
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Tengler
Officer — Chief Technology Officer
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 9:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $25.50 | Sep 1, 2015 | A | 43,032 | A | — | Sep 1, 2025 | Common Stock | 43,032 | 43,032 | D |
Explanation of responses
- F1This stock option vests in equal yearly installments over a four-year period which began on September 1, 2015.